MYEZOM BORTEZOMIB INJECTION

Get a Price/Quote

MYEZOM BORTEZOMIB INJECTION Specification

Indication
Multiple myeloma, Mantle cell lymphoma

Salt Composition
Bortezomib 2 mg

Origin of Medicine
Allopathic

Pacakaging (Quantity Per Box)
1 Vial

Dosage Form
Lyophilized Powder for Injection

Drug Type
Cytotoxic drug

Ingredients
Bortezomib

Physical Form
Injection

Recommended For
Multiple Myeloma & Mantle Cell Lymphoma

Dosage
As directed by physician

Dosage Guidelines
Inject intravenously or subcutaneously as per doctors advice

Suitable For
Adults

Quantity
One Vial per box

Storage Instructions
Store below 30C. Protect from light.

MYEZOM BORTEZOMIB INJECTION Trade Information

Packaging Details
PACK OF 1 VIAL

About MYEZOM BORTEZOMIB INJECTION

MyezomThis medication is a cancer chemotherapy drug used to treat certain types of tumors like multiple myeloma,mantle cell lymphoma. It blocks certain proteins which helps to slow the growth and spread of the cancer

Available as: 2 Mg & 3.5 Mg

Specification

Product Name: Myezom
Contains:Bortezomib
Form: Vial
Strength: 2 Mg & 3.5 Mg
Manufactured by: Dr.reddys

NOTE:- Myezom is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug...............

Usage and Administration

MYEZOM Bortezomib Injection is suitable for adult patients diagnosed with multiple myeloma or mantle cell lymphoma. The medication is administered either intravenously or subcutaneously, depending on the treating physicians instructions. Prior to injection, it must be reconstituted with sterile 0.9% sodium chloride. Precise dosing and administration should always be guided by qualified medical professionals.

Storage and Stability

The injection comes as a lyophilized powder in a single-dose vial, ensuring stability for up to 24 months when stored below 30C and kept protected from light. Proper storage is crucial to maintain its potency and effectiveness throughout the shelf life.

FAQs of MYEZOM BORTEZOMIB INJECTION:

Q: How should MYEZOM Bortezomib Injection be administered?

A: MYEZOM Bortezomib Injection must be administered either intravenously or subcutaneously, strictly following the dosage and method prescribed by your physician.

Q: What is the process for preparing MYEZOM Bortezomib Injection before use?

A: Before administration, the lyophilized powder in the vial should be reconstituted with sterile 0.9% sodium chloride injection, as instructed by the healthcare professional.

Q: Where should MYEZOM Bortezomib Injection be stored to maintain its efficacy?

A: The vial should be stored below 30C and protected from light. Proper storage ensures the medicine remains effective during its full 24-month shelf life.

Q: When is MYEZOM Bortezomib Injection indicated for use?

A: It is recommended for adults diagnosed with multiple myeloma or mantle cell lymphoma and should only be used when prescribed by a qualified healthcare provider.

Q: What benefits does MYEZOM Bortezomib Injection offer to patients?

A: MYEZOM delivers effective treatment for multiple myeloma and mantle cell lymphoma, helping to manage and impede the progression of these serious conditions under professional supervision.

Q: Is MYEZOM Bortezomib Injection suitable for self-administered use?

A: No, MYEZOM should only be prepared and administered by healthcare professionals in clinical settings due to its cytotoxic nature and precise dosing requirements.

Q: What are the key precautions to follow during the use of MYEZOM Bortezomib Injection?

A: Always ensure reconstitution with sterile 0.9% sodium chloride, adhere strictly to prescribed dosage, and avoid exposure to light or temperatures above 30C to prevent loss of efficacy.

Tell us about your requirement